In September, FDA cleared BrainScope’s first handheld medical device “Ahead 300” to use to assess the full spectrum of Traumatic Brain Injury (TBI). The device developed by BrainScope in partnership with the Department of Defense (DOD) www.defense.gov provides a multi-model model device offering clinicians a comprehensive panel of data to help diagnose TBI including concussions.
The medical device can be used in important healthcare settings, including hospital emergency departments, urgent care centers, concussion clinics, and other departments throughout the military health system.
The medical devices captures BrainScope’s patent-protected EEG capabilities using sophisticated algorithms and machine learning to analyze head-injured patient data. The device uses state-of-the-art handheld smartphone technology and a disposable electrode headset. The device also enables clinicians to receive a digitized streamlined reports.
“Ahead 300” represents an evolution from the three BrainScope www.brainscope.com products that previously have received FDA clearance and with added capabilities will be the first product the company will sell commercially.
Specifically, the device was supported by the Army’s Medical Research and Materiel Command under Contract No W81XWH-14-C-1405 and by the Army Contracting Command, Aberdeen Proving Ground along with the Natick Contracting Division under Contract No. W911QY-14-C-0097.
In another recent development at DOD, the Mobile Computing Capability (MCC) a medical application managed by the Joint Operational Medicine Information Systems (JOMIS) program within the Defense Healthcare Management System www.health.mil/dhms is helping first responders provide treatment to patients in the military.
MCC operates on Android phones, tablets, and allows first responders to document patient status and treatments rendered at the point of injury. The MCC application can function in low and no communication environments and stores data on the device until it can upload to the EHR via AHLTA Theater. MCC also enables first responders to have access to reference materials along with diagnostic and treatment decision support tools, as well as retrieve demographic data.